DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Panova-Noeva M, Marchetti M, Buoro S. et al.
JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.
Blood 2011;
118: 2599-2601.
We do not assume any responsibility for the contents of the web pages of other providers.